BOSTON, MA, Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C round.
Biofourmis Scoops Up $100M Series C Round
BOSTON, MA, Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C round.
